We are live on ! Find out more
CCM

Catapult Capital Management Portfolio holdings

AUM $265M
1-Year Est. Return 21.83%
This Fund
S&P 500
This Quarter Est. Return
-6.98%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
-$431M
Cap. Flow
-$403M
Cap. Flow %
-152.44%
Top 10 Hldgs %
27.43%
Holding
286
New
68
Increased
19
Reduced
60
Closed
135

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$9.98M
2
NUVA
NuVasive, Inc.
NUVA
+$4.39M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.85M
4
BSX icon
Boston Scientific
BSX
+$3.16M
5
PFE icon
Pfizer
PFE
+$3.04M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$16M
2
ABBV icon
AbbVie
ABBV
+$15.9M
3
ZTS icon
Zoetis
ZTS
+$13.5M
4
PEP icon
PepsiCo
PEP
+$12.8M
5
MCK icon
McKesson
MCK
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 41.36%
2 Consumer Discretionary 7.36%
3 Industrials 6.49%
4 Technology 4.09%
5 Financials 3.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYK icon
226
Stryker
SYK
$133B
– –
-5,000
Closed -$478K
TEL icon
227
TE Connectivity
TEL
$59.9B
– –
-35,378
Closed -$2.27M
THC icon
228
Tenet Healthcare
THC
$21.8B
– –
-33,611
Closed -$1.95M
TMO icon
229
Thermo Fisher Scientific
TMO
$214B
– –
-50,000
Closed -$6.49M
TMUS icon
230
CALL
T-Mobile US
TMUS
$186B
– –
-50,000
Closed -$1.94M
TSN icon
231
Tyson Foods
TSN
$21.4B
– –
-42,889
Closed -$1.83M
TT icon
232
Trane Technologies
TT
$97.3B
– –
-11,383
Closed -$767K
USO icon
233
CALL
United States Oil Fund
USO
$2.12B
– –
-25,000
Closed -$3.98M
VLO icon
234
Valero Energy
VLO
$92.6B
– –
-7,982
Closed -$500K
VMC icon
235
Vulcan Materials
VMC
$35.2B
– –
-8,651
Closed -$726K
VTR icon
236
Ventas
VTR
$44.7B
– –
-16,242
Closed -$1.15M
VTRS icon
237
Viatris
VTRS
$20.7B
– –
-12,591
Closed -$854K
VYX icon
238
CALL
NCR Voyix
VYX
$1.12B
– –
-40,750
Closed -$753K
WAB icon
239
Wabtec
WAB
$49.4B
– –
-25,054
Closed -$2.36M
WMT icon
240
Walmart Inc
WMT
$884B
– –
-55,242
Closed -$1.31M
X
241
CALL
DELISTED
US Steel
X
– –
-100,000
Closed -$2.06M
XPO icon
242
XPO
XPO
$23.4B
– –
-94,604
Closed -$1.48M
MTUS icon
243
Metallus
MTUS
$826M
– –
-3,338
Closed -$90K
CHUY
244
PUT
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
– –
-40,000
Closed -$1.07M
AERI
245
DELISTED
Aerie Pharmaceuticals
AERI
– –
-10,000
Closed -$177K
TMX
246
DELISTED
Terminix Global Holdings, Inc.
TMX
– –
-139,969
Closed -$3.39M
CERN
247
DELISTED
Cerner Corp
CERN
– –
-15,000
Closed -$1.04M
ALXN
248
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-15,000
Closed -$2.71M
HDS
249
DELISTED
HD Supply Holdings, Inc.
HDS
– –
-31,751
Closed -$1.12M
AMAG
250
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-75,000
Closed -$5.18M
8 9
10
11 12

Similar funds

LOCB
Lombard Odier & Cie (Bahamas) Nassau, Bahamas $263M AUM 3.37% 1-Year Est. Return
AF
Adirondack Funds Guilderland, New York $261M AUM
TCOTO
Trust Company of the Ozarks Springfield, Missouri $290M AUM 12.7% 1-Year Est. Return
DCM
Dinsmore Capital Management Morristown, New Jersey $230M AUM 0.29% 1-Year Est. Return
SCA
Samson Capital Advisors New York $228M AUM 0.84% 1-Year Est. Return
LPVHS
Lexington Partners VI Holdings Sub New York $227M AUM 24.75% 1-Year Est. Return
ATC
Argent Trust Company Ruston, Louisiana $225M AUM 5.44% 1-Year Est. Return
TFF
Timothy F. Fidgeon $203M AUM 2.36% 1-Year Est. Return

Catapult Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Catapult Capital Management held 286 positions worth $265M, down 62% from $696M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Catapult Capital Management withdrew a net $403M in Q3 2015, closing 135 positions and reducing 60 holdings. Its most notable exit was PepsiCo, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 43% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Catapult Capital Management opened a new position in Vertex Pharmaceuticals worth $3.12M.

  • Catapult Capital Management's largest Q3 2015 buy was Vertex Pharmaceuticals: 30,000 shares worth $3.12M.
  • Catapult Capital Management added most to Allergan plc in Q3 2015, an estimated $9.98M increase.
  • Catapult Capital Management's biggest Q3 2015 reduction was CVS Health, cutting an estimated $16M.
  • Catapult Capital Management fully exited PepsiCo in Q3 2015, selling an estimated $12.8M.
  • Catapult Capital Management's ten largest holdings make up 27% of its $265M portfolio in Q3 2015.
  • Catapult Capital Management opened 68 new positions and closed 135 in Q3 2015.
  • Catapult Capital Management's portfolio value fell 62% quarter-over-quarter to $265M.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.